NeuGuide™ FDA - Cleared in 2016 from a woman-led company with innovation in women's health.

NeuGuide™

A truly minimally-invasive, meshless and dissectionless anchoring system for the treatment of uterine prolapse.

MINIMALLY INVASIVE

COST EFFECTIVE

EFFECTIVE

SAFE

NeuGuide™ FDA - Cleared in 2016 from a woman-led company with innovation in women's health.

NeuGuide™

A truly minimally-invasive, meshless and dissectionless anchoring system for the treatment of uterine prolapse.

MINIMALLY INVASIVE

COST EFFECTIVE

EFFECTIVE

SAFE

The NeuGuide™ is a truly minimally-invasive, meshless and dissectionless anchoring system for the treatment of uterine prolapse.

The NeuGuide™ device is composed of two main elements: an anchor unit and a delivery system. The delivery system enables the guidance, insertion and deployment of the anchor unit. The anchor is designed to be introduced through the vaginal wall and secured to the ligament to provide pelvic floor stabilization

ADVANTAGES
  • No use of mesh
  • No dissection
  • Procedure can be completed in 15 minutes vs. 60-240 minutes for the standard of care
PATIENT BENEFITS INCLUDE
  • Avoids mesh related adverse events
  • Quicker patient recovery than the standard of care
  • Potential to take procedure to the outpatient clinic
  • No scarring
PRE-POST NEUGUIDE PROCEDURE